nonalcoholic fatty liver disease (nafld) is increasing in pediatric age group parallel to the growing prevalence of obesity and overweight all around the world. so changing in life style and   interventions on obesogenic environment is cornerstone of nafld therapy in obese children. some experts recommend that children and adolescents be encouraged to follow a low-fat, low-glycemic-index diet t...

CONTEXT Non-alcoholic fatty liver disease (NAFLD) is a chronic liver disease, with 5-10% of liver having extra fat. Increase in its prevalence in all age groups is linked with obesity and Type II diabetes. The treatment of NAFLD remains controversial. A growing body of evidence suggests a relation between overgrowth of gut microbiota with NAFLD and non-alcoholic steatohepatitis (NASH). The obje...

Background Non-alcoholic fatty liver disease (NAFLD) is one of the most common diseases, influenced by various risk factors associated with metabolic disorders. Currently there no specific effective treatment for NAFLD. Probiotics have been extensively researched their health benefit Probiotic Supplementation

Objectives: The aim of this study was to investigate the trends in research on non-alcoholic fatty liver disease (NAFLD) using Korean traditional medicine.Methods: This review included studies related treatment NAFLD, irrespective year publication. search terms were “nonalcoholic disease”, “non-alcoholic liver”, hepatitis”, “herb”, “herbal medicine”, “acupuncture”, and “traditional medicine”. a...

Background and objectives: Non-alcoholic fatty liver disease (NAFLD) is a common liver condition. On the other hand, coffee consumption has shown promising for gastrointestinal diseases.  Detection of the most valuable biomarkers of decaffeinated coffee treatment in healthy and non-alcoholic fatty liver disease conditions was the aim of the present study. Methods:</stro...

Type 2 diabetes mellitus is associated with dyslipdemia, insulin resistance and non alcoholic fatty liver disease. The purpose of the current study was to assess whether type 2 diabetes mellitus-induced hyperglycemia has an effect on the lipid profile and release of oxidative stress markers and inflammatory mediators in patients with non alcoholic fatty liver disease and normal liver function t...